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The deposition, clearance and translocation of europium-doped gadolinium oxide nanoparticles in a mouse lung
were investigated experimentally. Nanoparticles were synthesized by spray flame pyrolysis. The particle size,
crystallinity and surface properties were characterized. Following instillation, the concentrations of particles in
organs were determined with inductively coupled plasma mass spectrometry. The protein corona coating the
nanoparticles was found to be similar to the coating on more environmentally relevant nanoparticles such as iron
oxide. Measurements of the solubility of the nanoparticles in surrogates of biological fluids indicated very little
propensity for dissolution, and the elemental ratio of particle constituents did not change, adding further support
to the contention that intact nanoparticles were measured. The particles were intratracheally instilled into the
mouse lung. After 24 hours, the target organs were harvested, acid digested and the nanoparticle mass in each
organ was measured by inductively coupled plasma mass spectrometry (ICP-MS). The nanoparticles were detected
in all the studied organs at low ppb levels; 59% of the particles remained in the lung. A significant amount of
particles was also detected in the feces, suggesting fast clearance mechanisms. The nanoparticle system used in
this work is highly suitable for quantitatively determining deposition, transport and clearance of nanoparticles from
the lung, providing a quantified measure of delivered dose.
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Exposure to particles in the fine and ultrafine size range
contribute to the development and exacerbation of re-
spiratory diseases and cardiovascular events in humans
[1]. This is especially true for susceptible populations
such as children with asthma [2,3]. In 1998, the National
Academy of Sciences issued a report on Research Prior-
ities for Airborne Particulate Matter [4] that defined de-
position patterns and fate of particles in the respiratory
tract, especially for individuals who are susceptible to
particulate matter (PM), as a high priority research area.
This includes the study of deposition in adults with
models of respiratory disease (such as asthma and
COPD) – and also in the developing lung. The current
study outlines a methodologic approach to address these* Correspondence: imkennedy@ucdavis.edu
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reproduction in any medium, provided the orissues in future studies. This approach involves actual
measurement of deposited and retained dose. This is an
important advance because, while the hypothesized ef-
fect of a remodeled asthmatic airway or the smaller air-
ways of a young child can be used to theoretically
predict increased deposition of fine and ultrafine PM,
and may also impact clearance, to date there has not
been a viable, highly efficient, low cost alternative that
will allow this to be directly measured in an animal
model. We propose the use of a new model particle to
address this issue.
Several mechanisms have been proposed to describe
toxicological responses due to nanoparticle exposure in-
cluding local inflammation of the lung that further
develops into systemic inflammation, and translocation
of particles to organs such as the heart or brain where
toxic effects are manifested [5]. The deposition, trans-
location and bio-distribution of nanoparticles, eitherd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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been reviewed previously [6,7].
Previous studies of translocation have made use of engi-
neered nanoparticles with properties that permit them to
be tracked in animal tissues, or to be imaged. Radioactive
tags have been commonly used for this purpose, including
technetium-99 m [8]. The tags are chemically attached to
nanoparticles but may become separated from the nano-
particles and give a false indication of location. Alternative
radio-labeled materials have been used – Kreyling [9], for
example, used radioactive iridium nanoparticles to study
translocation in an animal. In an alternative approach,
Choi et al. [10] used quantum dots and fluorescently la-
beled polystyrene particles to study early particle trans-
location in the first hour after instillation. The study was
confined to the lung and lymphatic system where concen-
trations were quite high and fluorescence imaging was
feasible for early time-points following exposure. This ap-
proach is not likely to be successful in detecting transloca-
tion to more peripheral organs where concentrations, and
hence fluorescence signals, are likely to be close to the
limit of detection and confounded by background auto-
fluorescence from tissues.
In both these examples, in common with other reported
studies of particle clearance and translocation, the parti-
cles do not model well materials that are environmentally
or technologically relevant; the coating of proteins on the
surfaces of particles that are presented to cells are unlikely
to represent more relevant materials such as metal oxides.
Humans are commonly exposed to metal oxide nanoma-
terials. For example metal oxide nanomaterials can be
associated with fugitive dust. One documented source of
fugitive dust is the erosion of mine tailings in high winds
and arid conditions. Metal oxide nanomaterials generated
from these locations can travel great distances, affecting
populations downwind of the site [11]. Ultrafine metal
oxides are emitted from combustion sources. Kennedy
[12] noted that metal oxides arise from components of en-
gine fuels and lubricants, as well as engine components.
The oxides of iron and zinc are the most common metals
emitted from engines, often in association with other
aerosol materials. Finally, metal oxide nanoparticles are
finding increasing application in nanotechnologies that in-
clude environmental sensing [13]. Inorganic lanthanide-
based nanoparticles are used in a range of biotechnologies
[14]. Aerosol synthesis methods [15] offer an attractive
and economical route to the production of these materials
in large amounts, leading to a growing concern with re-
gard to occupational exposures via inhalation during pro-
duction and handling.
We propose an alternative to the extant approaches
for evaluating translocation and clearance in vivo. In the
current study, oxides of gadolinium were synthesized in
an aerosol flame reactor. A key advantage in using metaloxide particles for translocation studies compared to radi-
olabeled particles, inert Au or quantum dots etc., is that
the protein corona adsorbed onto the particle will be simi-
lar to the corona on naturally occurring non-carbonaceous
PM. Doping with rare earth elements provides a con-
venient method of labeling, and also provides very high
sensitivity for the detection of the nanoparticles using
inductively-coupled plasma mass spectrometry (ICP-MS).
Gadolinium oxide is an ideal host material to support
strong optical emission from the lanthanide Europium
ion, and has a similar zeta potential to other commonly
occurring or engineered metal oxide nanomaterials.
Hence, in addition to the relevance to some of the
technological applications of Gadolinium oxides per se,
Eu:Gd2O3 is a good surrogate material for tracking a
metal oxide nanoparticle delivered to an animal.
The aerosol synthesis route is ideal for providing suffi-
cient aerosol for a future inhalation study. An aerosol
reactor provides sufficient process control to assure re-
peatable composition and size of the particles at concen-
trations that are environmentally relevant and that can be
delivered for extended periods. Particle size can be refined
using impactors to reduce the spread of droplet sizes, and
mobility classifiers can reduce the size spread of the final
metal oxide particles [16]. With suitable conditions, con-
founding gas-phase compounds such as NOx can be
reduced to insignificant levels.
The goals of this study were two-fold: 1) to provide a
proof-of-concept of the usefulness of nanoparticles of
this type for studying lung clearance rates and transloca-
tion over longer time-scales (on the order of a day); and




A representative TEM image of particles synthesized by
flame spray pyrolysis is shown in Figure 1. The particles
are approximately spherical with a majority of the particles
of approximately 80–100 nm diameter; a few larger clus-
ters (~500 nm) were also observed on the grid. Particle
sizes can be fine-tuned into specific size ranges by altering
spray droplets sizes and the concentrations of precursors
in solution. Further refinement can be achieved using
impactors to minimize the size distribution of the precur-
sor droplets, and mobility classification to eliminate aggre-
gates [16]. Aggregation seen in the image is likely due to a
sampling artifact that arises from the drying of the nano-
particle solution on the TEM grid. The dynamic light scat-
tering (DLS) number-weighted size distribution is shown
in the inset; the count mean hydrodynamic diameter is
84 nm, in good agreement with that observed by TEM.
The XRD spectrum for the particles in Figure 2 shows
peaks corresponding to monoclinic Gd2O3 ; the absence
Figure 1 Transmission electron microscopy image of flame synthesized Eu:Gd2O3 nanoparticles. Inset: number weighted (NW) particle size
distributions determined by dynamic light scattering. CMD, count median diameter.
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Eu2O3) suggests that the Gd and Eu atoms are well-
mixed within the particle. The Eu ion substitutes for the
Gd ion, forming a well-ordered crystal.; separate phases
of Gd or Eu are not evident in the XRD results. The
BET measurement indicated that the nanoparticles have
a specific surface area of 11.5 ± 1.0 m2 g−1. The BET ef-
fective diameter is determined by,
dBET ¼ 6ASρ ð1Þ
where As is the specific surface area and is the particle
density equivalent to that of bulk gadolinia of 7.41 g cm-3Figure 2 Powder x-ray diffraction spectra for Eu:Gd2O3 flame
synthesized nanoparticles. Diamonds correspond to major peaks for
monoclinic gadolinium oxide (PDF 00-042-1465) and inverted triangles
correspond to monoclinic europium oxide (PDF 00-034-0072).[17], leading to a dBET of 70.4 nm. The crystalline diam-
eter dXRD, calculated using Scherrer’s formula (described
in the Method section), was 66.5 nm and agrees well with
the BET specific diameter.Particle dissolution
The Eu ion is luminescent following excitation when it
is present in a suitable crystal host such as Gd2O3.
When the ion is in solution, its luminescence is com-
pletely quenched. The photoluminescence (PL) provides
an ideal measurement of the kinetics of dissolution of
these particles in a range of pH conditions. The PL in-
tensity is directly proportional to the amount of crystal-
based Eu ions in suspension as illustrated in Figure 3 at
pH 7 in buffer. The pH was then adjusted to study the
dissolution of particles. A base line for the particle PL
spectra was obtained by dissolving the nanoparticles in
HNO3 for which we expect to see zero PL. With all the
particles dissolved, indeed no measurable emission was
detected. The spectra of particle PL emission were col-
lected at several time points in each of the media of
interest (lung BALF and reduced pH PBS). The results
after 7 days are shown in Figure 4. The PL spectra of the
nanoparticle dispersions indicate that after 7 days, very
little or no dissolution of Eu ions occurred in either lung
BALF or low pH buffer solution down to pH 4. At pH 3
and below, some dissolution was observed. However,
such low pH conditions are not biologically relevant.
Figure 3 Photoluminescence spectrum of emission of Eu: Gd2O3 suspended in (a) lung serum, (b) PBS at pH 5 for periods up to




7 F3 transitions respectively. The intensity of
the signal is proportional to the number of Eu ions present in the Gd2O3 nanoparticles. A very small measurable reduction in emission, and
hence in mass of Eu present in a particle, is discernible after 170 hours.
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particles are inert for an extended period of time.
Intratracheal aspiration and translocation
Measurements of the fate of instilled nanoparticles 24 hours
after instillation are shown in Figure 5. Particles were
detected in all the organs that were studied, although a
large fraction of the instilled particles remained in the lung.
A significant portion of the dose was found in the feces as
shown in Figure 5, suggesting that particles were being
cleared from the lung into the gastrointestinal tract. The
total mass of the instilled NP was 6416 ng ± 798 ng of
which 5326 ng ± 662 ng were recovered by ICP-MS data,
resulting in a total delivered dose recovery of 83% (Table 1).Figure 4 Photoluminescence spectra of Eu emission at various
pH after 170 hours.We have raised the concern with regard to dissolution
earlier and addressed that concern by examining the PL
of the Eu ion doped into its crystal host. Our unique
particle composition offers yet another check on the in-
tegrity of the nanoparticles as they interact with cells
and biological fluids. If particles are intact as they trans-
locate or clear, the ratio of Eu to Gd must remain the
same. Maintenance of the original Gd:Eu ratio is a ne-
cessary, but not sufficient, condition to ensure the integ-
rity of the particles – it is an additional confirmation
that we are measuring intact nanoparticles and notFigure 5 Mass of nanoparticles found in mouse tissue samples
(24 hours after instillation). Error bars are one standard deviation
(n = 4).
Table 1 Mass recovery of Eu:Gd2O3 nanoparticles by ICP-
MS 24 hr after oropharyngeal instillation in mice
Tissue Recovered mass (ng) Percent of delivered dose (%)
Lung 3786 ± 540 59.0
Feces 1306 ± 301 20.4
GI tract 69 ± 35 1.1
Liver 15.9 ± 2.4 0.2
Heart 3.5 ± 0.9 < 0.1
Spleen 2.6 ± 0.1 < 0.1
Kidney 2.5 ± 0.4 < 0.1
Blood 1.3 ± 0.8 < 0.1
Abid et al. Particle and Fibre Toxicology 2013, 10:1 Page 5 of 10
http://www.particleandfibretoxicology.com/content/10/1/1dissolved ions. The ratio of gadolinium to europium ions
measured by ICP-MS was analyzed for all tissue samples.
The target Gd:Eu ratio was 4.74 based on the initial pre-
cursor concentrations of Gd and Eu nitrates. Figure 6
shows the measured Gd:Eu ratio. In general, the data
satisfy the necessary condition for the integrity of the
nanoparticles. The spleen data showed large uncertainty
in the measured Gd:Eu because the concentrations of
Gd+3 and Eu+3were close to the detection limit of the
instrument.
A dynamic protein corona is known to form around
nanoparticles suspended in physiological fluid such as
lung serum [18,19]. The BCA assay for adsorbed protein
indicated that the amount of BSA adsorbed per particles
was 308 mg of protein per g of particles. Li et al. studied
protein adsorption on flame-synthesized iron oxide and
showed similar quantities of BSA (348 mg of BSA/g ofFigure 6 Ratio of gadolinium to europium ions used as an
internal standard as measured by ICP-MS. Dotted line represents
target value (4.74) based on initial precursor Gd/Eu ratio used in
flame synthesis of nanoparticles.particle) on the nanoparticles [20]. The approximate





where S is the mass of surface-adsorbed protein per
mass of particles, ρ is the particle density (7.41 g/cm3
for bulk gadolinium oxide), D = 70 nm is the spherical
equivalent particle diameter, and C the protein surface
density (0.29 μg of protein/cm2for BSA) – leading to S =
33.6 mg of protein per g of nanoparticle. A comparison
with the experimental result suggests that several layers
of protein, not a monolayer, coated the particles. The af-
finity to protein can be attributed to a negative surface
charge on Eu:Gd2O3 particles (ζ = −27.7 ± 0.46 mV).
Flame synthesized titanium oxide nanoparticles [23], for
example, have a similar surface charge and comparable
interactions with biomolecules is expected [24].
Discussion
The use of lanthanide/rare earth doping of metal oxide
nanoparticles has proven to be highly effective as a meas-
ure of dose and translocation in vivo. The particles are
relatively simple to synthesize and the method is well sui-
ted to eventual application to inhalation studies. The very
high sensitivity of ICP-MS offers a host of new possibilities
for dosimetry and deposition studies. Although the basic
approach is appealingly simple, we have found that in
practice it is very difficult to avoid cross-contamination of
samples at the very low levels that are demanded by ICP-
MS detection – extraordinary care is necessary during the
excision of organs and also during the digestion process,
particularly during the separation of control tissues from
exposed tissues. Our overall mass balance, based on the
true mass input of lanthanides versus the mass recovered,
is 83% ± 10% (Table 1). It is very likely that some of the
lanthanide that is unaccounted for is present in the fur or
carcass that was not digested. The syringe dead volume,
used to instill lanthanide NP, was measured gravimetri-
cally and resulted in a decrease of the delivered dose by
2.7% ± 0.7%; this was accounted for in the mass balance.
Feces were collected from the bedding and although ex-
treme care was taken to retrieve almost the entire sample,
incomplete recovery could be another source of error.
Urine samples studied using metabolism cages (data not
shown here) did not indicate the presence of lanthanide
ions by ICP-MS. In this study, no assumptions were made
regarding the rates of fast clearance; 21.4% of the instilled
dose was recovered from the feces and GI tract. A trans-
location study of 20 and 80 nm radioactive iridium parti-
cles instilled in rats and mice showed 95% total mass
recovery with typical uncertainties related to radiological
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to 100% mass recovery for 1.4 and 18 nm gold particles
intratracheally instilled in rats [25]; the mass removed
from the lung by fast clearance was estimated (up to 25%)
and subtracted from the delivered dose. The total mass
balance determined in this work is comparable to these
previous studies, within experimental error. Clearly, par-
ticle size also determines ability to translocate. Kreyling
et al. [9] found that iridium particles of 15 nm were much
more capable of translocating from the lung tissue than
80 nm particles.
The number-weighted mean diameter of our particles
in suspension in buffer, as delivered to the animals, was
84 nm with a relatively narrow size distribution as mea-
sured by dynamic light scattering. We are able to vary
this size in our method by controlling independently
two parameters: (1) precursor concentrations in the
solutions, the easiest parameter to change; (2) the size of
droplets formed in our spray. Inhalation experiments
that will follow on from this methodology study will
examine this important issue.
As shown in Table 1, 24 hours after nanoparticle in-
stillation, 59% of the initial dose was measured in the
lung, 20% was excreted in the feces, 0.2% was detected
in the liver and less than 0.1% of the delivered dose was
detected in the remaining organs. These results are
qualitatively similar to those found by Kreyling et al. [9]
for 15 and 80 nm iridium particles intratracheally in-
stilled in adult rats; after 7 days, 59% of the delivered
dose was found in the lungs, 35% was fecally excreted
and less than 0.2% found in extrapulmonary organs. In
contrast, studies of 40 and 100 nm gold nanoparticle
that were instilled intratracheally did not yield measur-
able signal in the liver or other organs [26]. This could
be due to different protein coating on gold compared to
Eu:Gd2O3 nanoparticles or comparable flame-generated
metal oxide particles.
It is possible that metals are not transported in ani-
mals as nanoparticles but rather as dissolved ions, which
could have a quite different propensity for translocation
and clearance. Our particles offer yet another advantage:
a straightforward means to estimate the rates of dissol-
ution within physiologically relevant media. Our ability
to track dissolved versus bound Eu in a particle via
photoluminescence offers a way to determine the im-
portance of nanoparticle dissolution. We have found
very little evidence of dissolution after 7 days in either of
the simulated fluids that particles may encounter: lung
BALF and low pH buffer, the latter designed to simulate
a lysosomal condition. Further evidence for this asser-
tion comes from examination of the Gd:Eu ratio in
recovered tissues – the ratio of the metal ions in the
measured samples remains the same. It is unlikely that
these ions would diffuse at precisely the same rate,therefore, the ratio measurements indicate that it was
likely that the elements translocated together within the
particle and that this is the primary contributor to the
observed clearance and translocation processes that we
have measured.
This experimental method promises to provide new
insights into clearance and deposition, with a quantifiable
dose. Dose at the target site is proportional to biologic ef-
fect – this is a basic tenet of toxicology. Yet when it comes
to inhalation dosimetry, air pollution standards and most
animal exposures characterize the concentration of parti-
cles in the air on the basis of mass per volume as the
“dose”. This does not account for the actual mass depos-
ited into the initial target tissue – the respiratory tract –
which can be affected by disease, age, exercise etc. Local
toxic effects are of special interest for ultrafine particles
because they have a larger total surface area for an equiva-
lent mass of larger particles and a long retention time in
the lung. While there has been recent notable progress in
using computational models to predict total respiratory
tract deposition, confirmation of the models with experi-
mental data has lagged [27]. If we could inexpensively, re-
liably, and with great sensitivity, track inhaled particles in
the body, it would revolutionize the field of inhalation
toxicology and allow the interpretation of biological re-
sponse in relation to delivered, and retained, dose.
While radionuclides have shown promise for this pur-
pose, with sensitivity in the range of 1 ppm [9,28,29],
issues of containment and cleanup have limited their use-
fulness. Stable isotopes exhibit some promise [30]. Fluor-
escent beads [31] and quantum dots are useful for short
term studies, particularly intracellular tracking studies, but
issues of photo-bleaching and toxicity [32], respectively,
can limit their usefulness. The particles described in the
current study are a breakthrough in this respect because
they are synthesized as part of a flame pyrolysis process
and so lend themselves readily to inhalation exposure
studies. Furthermore, they can be fine-tuned into specific
size ranges by altering spray droplets sizes and the con-
centrations of precursors in solution.
We chose to use oropharyngeal aspiration for these
initial studies because dose can be readily controlled and
the particles delivered as a relatively large bolus, which
is desirable for studies of translocation and testing of the
range of detection. We acknowledge that this method
does not approximate a true inhalation exposure and is
not appropriate for studies of short-term clearance,
which would be more appropriately addressed using an
inhalation model [6,33]. Furthermore, some aggregates
of particles were detected and this can affect deposition
and translocation characteristics, but these aggregates
were a small percentage of the total number of particles
instilled. This is a limitation of the instillation approach
and will be addressed in future studies of aerosols.
Figure 7 Flame spray pyrolysis burner schematic used for
synthesizing Eu:Gd2O3 nanoparticles.
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The first phase occurs primarily in the 24 hours after
dosing and is dominated by conducting-airway mucocili-
ary clearance of the particles to the larynx and then to
the GI tract and feces [28]. The second phase, which is
thought to involve macrophage-mediated clearance from
the peripheral lung, occurs after 24 hours and can last
for a long time (hundreds or thousands of days) depend-
ing on the particle type [33]. The major issue with par-
ticle tracking following respiratory tract deposition is
that only a very small percentage of the particles escape
the lung and circulate to other organs (this varies based
on particle size and has been estimated as < 0.1% for par-
ticles in our size range [28]). This means that for a
method to be useful for particle tracking, it needs to be
exquisitely sensitive to a very small number of particles.
Our approach using Eu:Gd2O3 particles can detect
particle loads in the ppb range. However, simply estimat-
ing particle mass in a whole organ will likely not be suf-
ficient; the logical next step for biological investigations
will be to define the extracellular and intracellular loca-
tion of the particles, preferably with the same particles
from the same exposure that characterized the local
dose. This is the goal of future studies and will be facili-
tated by the native phosphorescence of these particles
that will allow them to be visualized microscopically.
Conclusion
The translocation of aspirated particles in mice was
studied using flame-synthesized europium-doped gado-
linium oxide nanoparticles. The particles were charac-
terized for size, surface charge and morphology. The
flame-synthesized particles were a good surrogate for
typical metal oxide ultrafine particles that can be pro-
duced by a variety of synthesis routes. Particle dissol-
ution in typical biological media was evaluated using
photo-luminescent emission and was found to be insig-
nificant over the 24 hour period of this study. The ma-
jority of the particles remained in the lung after
24 hours. Particles were also detected in the gastro-
intestinal tract and feces suggesting a fast clearance of
some of the particles out of the lung. Small but detect-
able signals were quantified in all the organs that we
studied with the highest concentration found in the
liver. Negligible amounts were found in the blood, sug-
gesting clearance from the blood by other organs. The
combination of metal oxide nanoparticles doped with a
rare earth element, along with ICP-MS elemental ana-
lysis, provides detection limits in the low ppb range.
The fact that the nanoparticles can be generated in an
aerosol process opens up the possibility that this ap-
proach can be used successfully in an inhalation expos-
ure study. The particles and approaches described here
can be used in future studies, in combination with sitespecific methods we have developed to study lung biol-
ogy [34] and inhalation exposures, to determine site
specific deposition within the respiratory tract, both
quantitatively and qualitatively. We can then, for the
first time, link dose with biological effect.
Methods
Particle synthesis
Europium doped gadolinium oxide nanoparticles were
synthesized using a flame spray pyrolysis technique and
a forced jet atomizer similar to that described by Dosev
et al. [35]. The burner schematic is shown in Figure 7.
This technique is well-suited for generating environmen-
tally relevant metal oxide nanoparticles in high concen-
trations with reasonable control on particle size [36].
Gadolinium and europium nitrate salts (35.5 mM and
9.3 mM respectively) were dissolved in ethanol and used
as the liquid precursor. The precursor was sprayed into
a hydrogen-air flame at 40 ml/hr using a syringe pump.
The precursor droplets were pyrolyzed to form nanopar-
ticles in the high temperature environment. The Gd:Eu
ratio measured by ICP-MS was 4.7 ± 0.1 and in agree-
ment with the initial precursor ratio (4.74) based on ni-
trate concentrations in the precursor. Particles were
collected on a cold finger by thermophoresis; the col-
lected powder was washed in Milli-Qultrapure (MQ,
18.3 MΩ-cm) water to remove any unreacted precursor
from the nanoparticles. The nanoparticles were dried
and stock solutions of 10 mg/mL were prepared in MQ
water for the instillation experiment.
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The nanoparticle morphologies were investigated using a
Phillips CM-12 transmission electron microscope (TEM)
operated at 120 kV. Nanoparticles were suspended in MQ
water and deposited on a 400 mesh copper TEM grid with
a carbon/Formvar® film (Ted Pella Inc. Redding CA. Prod
# 01754-F); excess liquid was wicked away.
The particle crystalline phase was identified using a
Scintag powder x-ray diffractometer (XRD) with Cu Kα
radiation operated at 45 kV and 40 mA.The powder was




where the shape factor K is 0.9 [37], λ is the incident x-
ray wavelength (=1.54 Å), β is the peak full width-half
maximum (FWHM) at Bragg angle θ = 32.5°.
The surface area of nanoparticles was measured with
the Brunauer-Emmett-Teller (BET) method using an
Autosorb-1 instrument (Quantachrome Instruments, Boy-
nton Beach, FL). A sample of 380 mg was measured with
nitrogen as the adsorbate. Hydrodynamic particle size
measurements were performed using a BIC 90Plus dy-
namic light scattering instrument
(Brookhaven Instruments, Holtsville, NY). The number-
weighted (NW) particle size distributions were calculated
by the 90Plus software (Brookhaven Instruments). The
particle concentration at the start of the DLS experiment
was 20 mg L-1 in MQ water. The solution was bath-
sonicated for one minute to disperse the particles. At least
five runs were measured and the results were averaged.
Zeta potential was measured by light scattering using
a BIC ZetaPlus instrument (Brookhaven Instruments
Corporation, NY). Particles were suspended in 1 mM
KCl with particle concentration of 100 mg L-1 and the
suspension was bath-sonicated for five minutes before
each sample measurement. At least five measurements
were made for each sample and the data were averaged.
Surface adsorbed protein quantification
Particles were suspended in either PBS (1x) or BSA
(100 mg/mL of dry protein in PBS (1x)) with particle
concentrations at 200 mg L-1. Particles were washed in
PBS (1x) three times. The solutions were bath-sonicated
for five minutes, centrifuged at 9500 g ; the supernatant
was replaced with PBS between washes to remove any
unbound protein. Surface adsorbed proteins were quan-
tified using the bicinchoninic acid (BCA) assay with bo-
vine serum albumin (BSA) as a calibration standard. The
absorption measurements (excitation wavelength, λ =
560 nm) were performed on a SpectraMax M2 cuvette/
microplate reader (Molecular Devices Inc, Sunnyvale
CA) using the SOFTmax PRO software. Samples werebath-sonicated before measurements. The measurements
were made with six replicates. A 96-well plate was used
with 200 μL in each well. After the reagent was added, the
well was incubated at 37°C for 30 minutes. The calibration
range extended between 20 to 500 μg/mL of BSA with R2
linearity of 0.998. The adsorbed protein concentration was
determined by subtracting the signal of uncoated bare par-
ticles from protein-coated particles.
Particle dissolution
We investigated the possibility that Eu and Gd ions are
translocated, not as nanoparticles, but as dissolved ions.
It is important to estimate the rate of dissolution of
these particles under conditions that approxim ate the
fluid in the lung and also the intracellular conditions of
an endosome. To obtain sufficient lung lavage fluid for
in vitro experiments of particle dissolution, lung bronch-
oalveolar lavage fluid (BALF) was obtained from adult
Sprauge-Dawley rats (N = 6), instead of the mice that
were used for the translocation studies. Briefly, rats were
euthanized with an overdose of pentobarbital given i.p.,
the trachea cannulated and a single volume of 35 ml kg-1
of buffered saline solution was lavaged into the lung three
times. The physiological conditions that are typical of a
cellular lysosome were modeled with PBS adjusted to a
pH of 5.
The Eu3+ ions in Gd2O3 emit light only when con-
tained within the host matrix. Any dissolution or leach-
ing of Eu3+ ions from the host Gd2O3 nanoparticle will
result in a drop in the photo-luminescence (PL). The PL
spectra of particle suspensions were obtained using a
Varian Cary Eclipse Fluorescence Spectrophotometer
equipped with a Xenon lamp as an excitation source.
The dry nanoparticles samples were dispersed in solu-
tions of lung serum and PBS at pH5 and sonicated for
15 min to obtain a transparent dispersion of nanoparti-
cles with a concentration of 200 μgml-1. In each case,
4 ml of the nanoparticle dispersion were added to a
quartz cuvette and excited at 250 nm to obtain the emis-
sion spectra of the nanoparticles over time. To investi-
gate the dissolution of the nanoparticles at different pH,
PBS solutions were adjusted to different pH (i.e. 2 to 7)




All animal experiments were performed under protocols
approved by the University of California Davis Institu-
tional Animal Care and Use Committee in accordance
with NIH guidelines. For studies of particle translocation
in vivo, adult (8 weeks) male NIH Swiss mice with a
weight of 25 to 30 grams were purchased from Harlan
Laboratories (Livermore, CA). Mice were delivered one
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facility at the Center for Health and the Environment,
University of California Davisand provided with Labora-
tory Rodent Diet (Purina Mills, St. Louis, MO) and
water ad libitum.
Oropharyngeal aspiration of particles
Oropharyngeal aspiration in mice is an attractive alterna-
tive to direct tracheal instillation because it results in less
variability among animals and gives a more uniform pul-
monary distribution of the administered particles [38].
Mice were anesthetized using a Quantiflex anesthesia ma-
chine (Midmark Corp., Versailles, OH) equipped with an
isoflurane vaporizer. Mice were placed in a Plexiglass®
box connected to anesthesia machine. A mixture of 2.5%
isoflurane and oxygen was delivered at a rate of 1 L/min
to effect, approximately five minutes. Once anesthetized, a
known concentration of particles (40 μL dose of 0.160 ±
0.02 g L-1 Eu/Gd PM suspended in MQ water) was
pipetted into the oropharynx and aspirated into the lungs
[39]. Mice were monitored until recovery. The dead vol-
ume of the instillation system (Product # RSPSMI, Kent
Scientific, CT) was determined gravimetrically. Following
recovery from anesthesia, each mouse was placed in an in-
dividual cage. N = 4 per group
Necropsies and organ harvest
Tubes were weighed before and after sample was col-
lected. Mice were euthanized an overdose of pentobar-
bital (150 mg/kg) given i.p and exsanguinated. Blood
was collected and the abdominal cavity was opened and
the spleen, kidneys and liver were removed. Then the
thoracic cavity was opened and the heart and lungs were
removed. Finally, the stomach and intestines were
removed as a unit. Feces from the cages were collected
and the remaining carcass was weighed and frozen at
−80°C. Minced, tissues, blood and feces were placed in
individual 15 mL polystyrene conical tubes (BD Bios-
ciences, Franklin Lakes, NJ) for processing. Instruments
were cleaned in DI water and rinsed in 70% ethanol be-
tween uses to prevent cross contamination.
Tissue acid digestion and ICP-MS analysis
Tissue samples were digested in trace metal grade nitric
acid and hydrogen peroxide for elemental analysis. Acid
digestion occurred at 70°C for 24 hours followed by
hydrogen peroxide (70°C) digestion overnight. Tissue
samples were diluted with MQ water to an acid concen-
tration of 6%.
The concentrations of elemental gadolinium and euro-
pium were quantified using inductively coupled plasma
mass spectrometry (ICP-MS). The ICP-MS instrument
was calibrated using a NIST traceable standard for Eu and
Gd. The standards came in stock solution at 1000 ppband 100 ppb; serial dilutions of 500, 200 and 100 ppb were
used at the high end of the concentration range and 100,
10, 1 and 0.1 ppb for the low concentration standard to
generate the calibration curve. The instrument level of de-
tection (LOD) was 1.9 ppt (parts per trillion) for Eu and
2.7 ppt for Gd and the BEC (background equivalent con-
centrations) is 1.6 ppt for Eu and 3.9 ppt for Gd. The
LOD and BEC are determined by instrument rinses with
at least n = 5 throughout the experimental run on a par-
ticular day. Blank tissues were used as a control; the ICP-
MS analysis of Eu indicated a maximum concentration in
these tissues of 0.1 ppb, setting a lower limit to our sensi-
tivity in the exposure experiments that translates to a limit
of quantification of about 4 ng in the lung samples and
about 1 ng in the kidneys.
Quality control of the ICP-MS analysis and the integrity
of nanoparticles was checked by comparing the measured
Gd:Eu ratio from tissue samples to that of the original
nanoparticles, ensuring that the elemental signal was from
nanoparticles and not from the background, and that ana-
lytical artifacts had not been introduced. Indeed, europium-
doped gadolinium oxide is suitable for this experiment as
both elements have a low natural abundance abundance.
The most common rare earth element is Cerium with a
natural abundance in the Earth’s crust of about 43 ppm
[40]; the least common is Thulium at 0.3 ppm. Europium
and Gadolinium are present in the Earth’s crust at around
the 1 ppm level. Good hygiene in the laboratory ensures
that the background levels in our experiments are well
below the natural level with our controls exhibiting con-
centrations at about 0.1 ppb.
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